BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1662880)

  • 1. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G; Scorer HJ; Carnegie CM
    J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections.
    Neldner KH
    Am J Med; 1991 Dec; 91(6A):111S-114S. PubMed ID: 1662879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
    Chodosh S
    Chest; 1991 Dec; 100(6):1497-502. PubMed ID: 1659975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
    Davey PG
    Am J Med; 1991 Dec; 91(6A):101S-105S. PubMed ID: 1662877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uncomplicated urinary tract infections with temafloxacin.
    Iravani A
    Am J Med; 1991 Dec; 91(6A):124S-128S. PubMed ID: 1662882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE; Philip E
    J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1991 Dec; 91(6A):129S-133S. PubMed ID: 1662883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.
    Nichols RL; Smith JW; Gentry LO; Gezon J; Campbell T; Sokol P; Williams RR
    South Med J; 1997 Dec; 90(12):1193-200. PubMed ID: 9404904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S; Lakshminarayan S; Swarz H; Breisch S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic bacterial prostatitis with temafloxacin.
    Cox CE; Childs SJ
    Am J Med; 1991 Dec; 91(6A):134S-139S. PubMed ID: 1662884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of quinolones in the treatment of infections of the skin and skin structure.
    Gentry LO
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():97-110. PubMed ID: 1787128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic management of cutaneous bacterial infections.
    Parish LC; Witkowski JA
    Am J Med; 1991 Dec; 91(6A):106S-110S. PubMed ID: 1662878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
    Cox CE
    Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.
    Iravani A
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1777-81. PubMed ID: 1952847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    Pernet AG
    Am J Med; 1991 Dec; 91(6A):162S-165S. PubMed ID: 1662888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.